Related Experiment Video
Updated: Aug 14, 2025

High-throughput Screening for Broad-spectrum Chemical Inhibitors of RNA Viruses
Published on: May 5, 2014
Current advances in antiviral RNA interference in mammals
Jiaxin Wang1,2, Yang Li1
1CAS Key Laboratory of Animal Ecology and Conservation Biology, Institute of Zoology, Chinese Academy of Sciences, Beijing, China.
Mammals possess innate immunity against viruses, including interferon response and RNA interference (RNAi). This review explores the functional role of antiviral RNAi in mammalian somatic cells, addressing key questions in ongoing research.
Area of Science:
- Immunology
- Molecular Biology
- Virology
Background:
- Mammals have robust innate immune systems to combat viral infections.
- Interferon (IFN) response is well-studied, while antiviral RNA interference (RNAi) is emerging.
- Previous research suggests low Dicer activity and IFN-mediated inhibition of RNAi in mammals.
Purpose of the Study:
- To review current advances in mammalian antiviral RNAi.
- To address fundamental questions regarding RNAi's role in innate antiviral immunity.
- To clarify the ongoing debate on RNAi functionality in mammalian somatic cells.
Main Methods:
- Literature review of existing research on antiviral RNAi in mammals.
- Analysis of studies investigating Dicer activity and IFN interactions with RNAi.
- Focus on key questions central to the RNAi antiviral immunity debate.
Main Results:
- The functionality of RNAi as an antiviral mechanism in mammalian somatic cells remains under investigation.
- Evidence suggests potential inhibition of RNAi by the interferon response.
- Dicer activity on dsRNA substrates in vitro has been reported as low.
Conclusions:
- The precise role and efficacy of RNAi in mammalian antiviral defense require further elucidation.
- Understanding RNAi's interplay with IFN response is critical.
- Ongoing research aims to resolve whether RNAi constitutes a functional innate antiviral immunity in mammals.
More Related Videos
12:03Evaluation of the Efficacy And Toxicity of RNAs Targeting HIV-1 Production for Use in Gene or Drug Therapy
Published on: September 5, 2016
06:02Arbovirus Infections As Screening Tools for the Identification of Viral Immunomodulators and Host Antiviral Factors
Published on: September 13, 2018
Related Concept Videos
Experimental RNAi
RNA Interference
This process occurs naturally in cells, often through the activity of genomically-encoded microRNAs. Researchers can take advantage of this mechanism by introducing synthetic RNAs to deactivate specific genes for research or therapeutic purposes. For example, RNAi could be used...
siRNA - Small Interfering RNAs
In the cytoplasm, siRNA is processed from a double-stranded RNA, which comes from either endogenous DNA transcription or exogenous sources like a virus. This double-stranded RNA is then cleaved by the...
Viruses with RNA Genomes
RNA Editing